Biotechnology company developing novel therapeutics that reverse mitochondrial dysfunction to arrest the progression of degenerative diseases
MitoRx Therapeutics has 1 recorded funding round in the Tech.eu database (amounts undisclosed). Based in Oxford, UK; active in Healthtech. Data as of 7 Aug 2026.
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2022-04-25 | Seed | — |
| Angel Investors,Longevitytech.fund,Oxford Technology Management,Science Angel Syndicate Network,The Fink Family Office,UK Innovation & Science Seed Fund+1 more |
| View deal → |
